Treatment for Dry Macular Degeneration
For years, patients diagnosed with dry age-related macular degeneration (AMD) had few treatment options available. While lifestyle changes, nutritional supplements, and routine monitoring could help slow progression, there was no FDA-authorized treatment specifically designed to improve vision in patients with dry AMD.
That changed with the introduction of Valeda® Light Therapy, an innovative, non-invasive treatment that uses photobiomodulation (PBM) technology to help support retinal health and improve visual function in eligible patients with dry macular degeneration. The Valeda Light Delivery System received FDA authorization in 2024 following positive results from the LIGHTSITE III clinical trial.
At the Eye Center of Northern Colorado, we are committed to bringing the latest advancements in eye care to our community. If you have been diagnosed with dry AMD, Valeda may offer a new way to preserve and potentially improve your vision.
Age-related macular degeneration (AMD) is a progressive eye disease that affects the macula, the central portion of the retina responsible for sharp, detailed vision. AMD is one of the leading causes of vision loss among adults over age 50.
Dry AMD is the most common form of the disease, accounting for approximately 80-90% of cases. As the condition progresses, patients may experience:
Because dry AMD develops gradually, many patients may not notice symptoms until vision loss has already begun.
Valeda Light Therapy is an FDA-authorized treatment that uses specific wavelengths of light to stimulate cellular function within the retina through a process known as photobiomodulation. Unlike injections or surgery, Valeda is completely non-invasive and does not require needles, incisions, or downtime.
The treatment delivers carefully controlled wavelengths of yellow, red, and near-infrared light to retinal cells. These wavelengths are designed to support mitochondrial function—the energy-producing structures within cells—which may help improve retinal health and visual performance.
One of the most appealing aspects of Valeda therapy is its simplicity.
Treatment is performed in the office and typically takes only a few minutes per session. Patients sit comfortably while the device delivers therapeutic light to each eye.
A standard treatment cycle consists of:
Many patients return immediately to their normal daily activities after each visit.
Valeda is intended for patients with dry age-related macular degeneration who meet specific clinical criteria. Generally, ideal candidates have:
A comprehensive retinal examination, imaging studies, and evaluation by an ophthalmologist are necessary to determine whether Valeda is appropriate for your individual condition.
Every patient responds differently, but clinical studies have shown encouraging outcomes.
In the LIGHTSITE III trial, patients receiving Valeda therapy demonstrated improvements in visual acuity and maintained those gains over time with repeat treatment cycles. Some participants experienced vision improvements equivalent to approximately one line on a standard eye chart.
While Valeda is not a cure for macular degeneration, it represents an important advancement for patients seeking proactive treatment before significant vision loss occurs.
Macular degeneration often progresses slowly, making it easy to delay treatment until symptoms become more noticeable. However, preserving retinal function before substantial damage occurs may offer the best opportunity for maintaining long-term vision.
Regular eye exams are critical for detecting AMD early and identifying treatment opportunities before vision loss impacts your quality of life.
If you have been diagnosed with dry macular degeneration—or have a family history of the disease—talk with your eye care provider about whether Valeda Light Therapy may be right for you.
At Eye Center of Northern Colorado, our experienced ophthalmologists and retina specialists are dedicated to providing advanced treatments for retinal diseases, including age-related macular degeneration.
We combine leading-edge technology with personalized care to help patients protect their vision and maintain their independence. If you are interested in learning more about Valeda Light Therapy or would like to schedule an evaluation, our team is here to help.
If you have dry macular degeneration and are looking for innovative treatment options, contact the Eye Center of Northern Colorado today. Our specialists can determine whether Valeda Light Therapy is appropriate for your condition and create a personalized treatment plan designed to help preserve your sight for years to come.